OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (10)

  1. Reyes María Martín-Rojas, Lucía Cayuela, Francisco Martín-Domínguez, Aurelio Cayuela. Myelodysplastic syndromes mortality in Spain: a comprehensive age-period-cohort and joinpoint analysis. Clin Transl Oncol 2023;26:917
    https://doi.org/10.1007/s12094-023-03321-3
  2. Min-Seung Park, Boram Kim, Jun Ho Jang, Chul Won Jung, Hee-Jin Kim, Hyun-Young Kim. Rare Non-Cryptic NUP98 Rearrangements Associated With Myeloid Neoplasms and Their Poor Prognostic Impact. Ann Lab Med 2025;45:53
    https://doi.org/10.3343/alm.2024.0190
  3. Xiangjun Ye, Zhikang Zheng, Yuwei Wu, Zhihui Zhang, Zhiping Xu, Yameng Liu, Lei Jiang, Jianguo Wu. NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study. 2024;103:e38556
    https://doi.org/10.1097/MD.0000000000038556
  4. Hyunwoo Kim, Ja Young Lee, Shinae Yu, Eunkyoung Yoo, Hye Ran Kim, Sang Min Lee, Won Sik Lee. Acute myeloid leukemia and myelodysplastic neoplasms: clinical implications of myelodysplasia-related genes mutations and TP53 aberrations. Blood Res. 2024;59
    https://doi.org/10.1007/s44313-024-00044-4
  5. Reyes María Martín-Rojas, Lucía Cayuela, Francisco Martín-Domínguez, Aurelio Cayuela. Unveiling sex-based geographical disparities in myelodysplastic syndrome mortality trends in Spain (1999–2022). Clin Transl Oncol 2024;26:2693
    https://doi.org/10.1007/s12094-024-03503-7
  6. Taylor Zak, Madina Sukhanova, Juehua Gao, Lucy Fu, Yi-Hua Chen, Qing Ching Chen, Amir Behdad, Hamza Tariq. Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts . Leukemia & Lymphoma 2024;65:1691
    https://doi.org/10.1080/10428194.2024.2367699
  7. Su Min Han, Sang Hyuk Park, Hyun-Ki Kim, Ji-Hun Lim, Joseph Jeong, Seon-Ho Lee. Diagnosis and Reclassification of Myelodysplastic Syndromes and Acute Myeloid Leukemia: Comparison Between the 2016 WHO 4th and 2022 WHO 5th/ICC Classifications. Lab Med Online 2024;14:208
    https://doi.org/10.47429/lmo.2024.14.3.208
  8. Lina Wang, Jiang Liu, Yafang Guo, Meiling Zhao, Bozheng Zhang, Junyan Zhang, Ruijuan Zhang. Outcomes and Risk Factors in Patients with Hematologic Malignancies Following Late-Stage SARS-CoV-2 Infection. JMDH 2024;Volume 17:5853
    https://doi.org/10.2147/JMDH.S491098
  9. Jiwon Yun, Hye Ryoun Kim. Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on SF3B1- and TP53-mutated Myelodysplastic Neoplasms. Ann Lab Med 2025;45:36
    https://doi.org/10.3343/alm.2024.0079
  10. Qihui Cai, Haiqiang Lan, Deng Yi, Bojun Xian, Luo Zidan, Jianqiao Li, Zhaohong Liao. Flow cytometry in acute myeloid leukemia and detection of minimal residual disease. Clinica Chimica Acta 2025;564:119945
    https://doi.org/10.1016/j.cca.2024.119945
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd